Agilon Health (AGL) Long-Term Investments (2021 - 2023)

Agilon Health (AGL) has reported Long-Term Investments for 3 consecutive years, with $5.1 million the latest figure, recorded in Q1 2023.

• Long-Term Investments for Q1 2023 came in at $5.1 million, down 28.86% year-over-year; the trailing twelve-month figure through Mar 2023 was $5.1 million (down 28.86% YoY), and the FY2022 annual result was $4.7 million, down 27.01% from the prior year.
• Long-Term Investments was $5.1 million for Q1 2023 at Agilon Health, up from $4.7 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $7.2 million in Q1 2022 and troughed at $3.6 million in Q2 2022.
• Average Long-Term Investments over 3 years is $5.6 million, with a median of $5.8 million recorded in 2021.
• Year-over-year, Long-Term Investments decreased 27.01% in 2022 and slipped 28.86% in 2023.
• Over 3 years, Long-Term Investments stood at $6.4 million in 2021, then dropped by 27.01% to $4.7 million in 2022, then grew by 10.5% to $5.1 million in 2023.
• Per Business Quant data, the three most recent Long-Term Investments figures were $5.1 million in Q1 2023, $4.7 million in Q4 2022, and $6.4 million in Q3 2022.